Trade 908 Devices Inc. - MASS CFD

Trading Conditions

• Spread: 0.05
• Long position overnight feeLong position overnight feeMargin. Your investmentUS$1,000.00Overnight feeCharges from full value of position-0.026179 %(-US$1.05)Trade size with leverage ~ US$5,000.00Short position overnight fee ~ US$4,000.00Go to platform: -0.026179%
• Short position overnight feeShort position overnight feeMargin. Your investmentUS$1,000.00Overnight feeCharges from full value of position0.003957 %(US$0.16)Trade size with leverage ~ US$5,000.00Short position overnight fee ~ US$4,000.00Go to platform: 0.003957%
• Overnight fee time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 20
• Stock exchange: United States of America
• Commission on trade: 0%

• Margin. Your investment: US$1,000.00
• Overnight feeCharges from full value of position: -0.026179 %
  (-US$1.05)

• Margin. Your investment: US$1,000.00
• Overnight feeCharges from full value of position: 0.003957 %
  (US$0.16)

Key Stats

• Prev. Close: 5.58
• Open: 5.38
• 1-Year Change: -29.02%
• Day's Range: 5.38 - 5.53

908 Devices Inc. Company profile

About 908 Devices Inc.

908 Devices Inc. offers a suite of purpose-built handheld and desktop mass spectrometry (Mass Spec) devices for the point-of-need. The Company's Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908, Rebel and ZipChip. MX908 is a handheld Mass Spec device designed for analysis of gas, liquid and solid materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. The Rebel is a desktop analyzer providing real-time information on the extracellular environment in bioprocesses. ZipChip is a plug-and-play separation platform that optimizes Mass Spec sample analysis.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, 908 Devices Inc. revenues increased 57% to $42.2M. Net loss applicable to common stockholders increased 72% to $22.2M. Revenues reflect North America segment increase of 60% to $35.5M, Europe,Middle East & Africa segment increase of 57% to $4.5M. Higher net loss reflects Selling, general and administrative increase from $12.1M to $30.3M (expense).